Blue Moon Metals Inc. is a Canadian mineral exploration and development company based in Toronto. It was previously known as Blue Moon Zinc Corp. before the 2021 name change that highlighted its broader critical-metals focus. The firm holds six brownfield polymetallic projects, with the standout Nussir copper-gold-silver asset in northern Norway designated as a Strategic Project under the EU’s Critical Raw Materials Act. Other holdings span zinc-gold-silver-copper, tungsten-molybdenum, germanium-gallium-copper, and gold-copper-zinc-silver properties across the United States. As a pre-revenue developer, Blue Moon relies on equity financings, which keeps the share price sensitive to both capital markets and commodity trends. Its investor base includes established names such as TECK, WPM, Oaktree Capital Management, Hartree Partners, and Altius Minerals.
Over the last 30 days, BMM declined approximately 36%, moving from a closing price near $4.93 on October 7 to $3.15 on November 6. Volume picked up notably in late October and early November, including a sharp intraday drop on November 4 that briefly pushed the stock under $3.00. This one-month move fits into a wider three-month decline of roughly 46% from levels around $5.80 in early August. The stock had touched a recent high near $6.19 in early September before the broader selloff erased most of the earlier 2026 gains.
A handful of company-specific items lined up with the drop. On October 19, Blue Moon closed a C$35 million non-brokered private placement with The Elmet Group (ELMT), issuing 3.5 million units at C$10.00 each to support development at the Springer tungsten project and adding a new board member. While the capital strengthens the balance sheet, the associated warrants and dilution potential weighed on sentiment for a pre-revenue name. On October 30, the company announced the mutual termination of its proposed acquisition of 33 tungsten and antimony projects in the western United States, alongside completing its corporate continuance from British Columbia to Ontario. Scotiabank kept a Buy rating and C$14.00 target on October 7, yet that note did not stem the selling. Broader swings in copper and critical-minerals equities added to the pressure.
The three-month decline followed earlier progress at Nussir, including an April 2026 feasibility study, an engineering-procurement-construction contract award, and key Norwegian permits that support a late-2027 production target. In August the company addressed a short-seller report from Viceroy Research on its permitting framework. Positive drilling results emerged at both Nussir and Springer, a strategic investment from The Elmet Group was announced in September, and tungsten prices rose, lifting the profile of the Springer complex. Even with these milestones, new financings, the terminated acquisition, and risk-off moves across junior mining equities produced the multi-month slide that accelerated in late October. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Looking forward, project execution and commodity prices remain the main variables. Construction milestones at Nussir will matter as the company targets first production in the fourth quarter of 2027 and full commercial output in 2028, along with ongoing drilling and permitting updates in Norway. Copper, tungsten, germanium, and gallium price movements will influence project economics and market tone. As a pre-revenue developer, any future equity raises carry potential dilution risk. The company’s response to earlier short-seller commentary, Norwegian permitting status, and further analyst notes will also be relevant. While Scotiabank maintains its Buy rating, execution risk, commodity volatility, and financing needs must be weighed against the company’s positioning in critical minerals. From what I see, these elements will continue to drive sentiment in the months ahead.
In my own work I occasionally look at Tickeron’s AI Trading Bots to understand how different automated strategies are positioned around development-stage names like this one. The platform offers a range of models with varying timeframes and risk parameters, which can provide an additional data point alongside fundamental research without replacing individual judgment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
BMM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 33 cases where BMM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMM advanced for three days, in 100 of 116 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMM as a result. In 66 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The Moving Average Convergence Divergence Histogram (MACD) for BMM turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 35 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for BMM entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 35 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.905) is normal, around the industry mean (6.813). P/E Ratio (0.000) is within average values for comparable stocks, (-0.701). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.026). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (283.864).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. BMM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry OtherMetalsMinerals